Takeshi Akiyoshi

600 total citations
50 papers, 461 citations indexed

About

Takeshi Akiyoshi is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Takeshi Akiyoshi has authored 50 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Pharmacology and 14 papers in Molecular Biology. Recurrent topics in Takeshi Akiyoshi's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Takeshi Akiyoshi is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Takeshi Akiyoshi collaborates with scholars based in Japan, United States and Finland. Takeshi Akiyoshi's co-authors include Hisakazu Ohtani, Kenji Matsuyama, Sumio Matzno, Noboru Okamura, Tomoko Nakamura, Takahiro Uchida, Toshikatsu Nakabayashi, Yohko Miyanaga, Koujirou Yamamoto and Katsunori Nakamura and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Life Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Takeshi Akiyoshi

47 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Akiyoshi Japan 12 123 109 99 81 59 50 461
Cong Xie China 17 275 2.2× 85 0.8× 121 1.2× 96 1.2× 26 0.4× 48 813
Yoko Taki Japan 11 143 1.2× 37 0.3× 188 1.9× 53 0.7× 23 0.4× 12 518
Hiroki Suzuki Japan 17 131 1.1× 63 0.6× 42 0.4× 50 0.6× 22 0.4× 62 677
Gianfranco Fornasini Australia 12 358 2.9× 42 0.4× 53 0.5× 55 0.7× 56 0.9× 14 872
Mark N. Mead United States 6 272 2.2× 117 1.1× 78 0.8× 101 1.2× 15 0.3× 6 700
Sung Joon Lee South Korea 15 188 1.5× 49 0.4× 63 0.6× 21 0.3× 20 0.3× 52 599
Yutaka Higashi Japan 16 151 1.2× 36 0.3× 122 1.2× 70 0.9× 21 0.4× 39 620
Toshiyuki Kudo Japan 16 195 1.6× 31 0.3× 137 1.4× 149 1.8× 24 0.4× 42 632
Gil‐Tae Gang South Korea 15 234 1.9× 64 0.6× 21 0.2× 117 1.4× 41 0.7× 21 595

Countries citing papers authored by Takeshi Akiyoshi

Since Specialization
Citations

This map shows the geographic impact of Takeshi Akiyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Akiyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Akiyoshi more than expected).

Fields of papers citing papers by Takeshi Akiyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Akiyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Akiyoshi. The network helps show where Takeshi Akiyoshi may publish in the future.

Co-authorship network of co-authors of Takeshi Akiyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Akiyoshi. A scholar is included among the top collaborators of Takeshi Akiyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Akiyoshi. Takeshi Akiyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyoshi, Takeshi, et al.. (2025). The effect of organic solvents on the in vitro transport activity of three OATP isoforms. Toxicology in Vitro. 107. 106059–106059.
2.
Uekusa, Yoshinori, Miyuki Shimoji, Hiroshi Yamazaki, et al.. (2024). Kinetics of the inhibition of CYP3A4 and CYP2C19 activity by jabara juice and identification of the responsible inhibitory components. Journal of Pharmaceutical Sciences. 114(2). 849–856. 1 indexed citations
3.
Kataoka, Hiroki, et al.. (2024). The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1. Journal of Pharmaceutical Sciences. 113(5). 1376–1384. 2 indexed citations
4.
Akiyoshi, Takeshi, K. Sakamoto, Yoshiaki Suzuki, et al.. (2023). Determination of single-molecule transport activity of OATP2B1 by measuring the number of transporter molecules using electrophysiological approach. Journal of Pharmacological Sciences. 153(3). 153–160. 1 indexed citations
5.
Akiyoshi, Takeshi, et al.. (2023). The Effects of Jabara Juice on the Intestinal Permeation of Fexofenadine. Biological and Pharmaceutical Bulletin. 46(12). 1745–1752. 3 indexed citations
6.
Watanabe, Daisuke, Miyuki Shimoji, Hiroshi Yamazaki, et al.. (2023). The influence of temperature on the metabolic activity of CYP2C9, CYP2C19, and CYP3A4 genetic variants in vitro. Xenobiotica. 53(5). 357–365. 1 indexed citations
7.
Akiyoshi, Takeshi, et al.. (2022). Comparison of the transport kinetics of fexofenadine and its pH dependency among OATP1A2 genetic variants. Drug Metabolism and Pharmacokinetics. 47. 100470–100470. 2 indexed citations
8.
Ohtani, Hisakazu, et al.. (2021). Estimation of absolute oral bioavailability without performing an intravenous clinical study. Drug Metabolism and Pharmacokinetics. 38. 100392–100392. 3 indexed citations
9.
Akiyoshi, Takeshi, et al.. (2021). Analysis of inhibition kinetics of three beverage ingredients, bergamottin, dihydroxybergamottin and resveratrol, on CYP2C9 activity. Drug Metabolism and Pharmacokinetics. 42. 100429–100429. 5 indexed citations
10.
Yamaguchi, Yuki, Takeshi Akiyoshi, Go Kawamura, et al.. (2021). Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants. Drug Metabolism and Pharmacokinetics. 38. 100384–100384. 14 indexed citations
11.
Akiyoshi, Takeshi, Ryo Sato, Yoshinori Uekusa, et al.. (2020). Citrus Fruit-Derived Flavanone Glycoside Narirutin is a Novel Potent Inhibitor of Organic Anion-Transporting Polypeptides. Journal of Agricultural and Food Chemistry. 68(48). 14182–14191. 13 indexed citations
12.
Akiyoshi, Takeshi, et al.. (2019). Effects of food type on the extent of drug-drug interactions between activated charcoal and phenobarbital in rats. Drug Metabolism and Pharmacokinetics. 34(4). 287–291.
13.
Akiyoshi, Takeshi, et al.. (2019). Inhibitory kinetics of fruit components on CYP2C19 activity. Drug Metabolism and Pharmacokinetics. 34(3). 181–186. 12 indexed citations
14.
Akiyoshi, Takeshi, et al.. (2018). The extent of drug-drug interaction between amlodipine and activated charcoal is attenuated by food intake in rats. Drug Metabolism and Pharmacokinetics. 34(1). 108–110. 1 indexed citations
15.
Akiyoshi, Takeshi, et al.. (2017). Inactivation kinetics and residual activity of CYP3A4 after treatment with erythromycin. Biopharmaceutics & Drug Disposition. 38(7). 420–425. 3 indexed citations
16.
17.
Akiyoshi, Takeshi, et al.. (2015). Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6. Drug Metabolism and Pharmacokinetics. 30(4). 321–324. 3 indexed citations
18.
Akiyoshi, Takeshi, Marie Ito, Mitsue Miyazaki, et al.. (2013). Mechanism-based Inhibition Profiles of Erythromycin and Clarithromycin with Cytochrome P450 3A4 Genetic Variants. Drug Metabolism and Pharmacokinetics. 28(5). 411–415. 24 indexed citations
19.
Matzno, Sumio, et al.. (2009). Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. Journal of Pharmacy and Pharmacology. 61(6). 781–788. 10 indexed citations
20.
Matzno, Sumio, Shinya YASUDA, Takeshi Akiyoshi, et al.. (2005). Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation. Life Sciences. 78(16). 1892–1899. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cong Xie Breakdown of academic impact, for papers by Yoko Taki Breakdown of academic impact, for papers by Hiroki Suzuki Breakdown of academic impact, for papers by Gianfranco Fornasini Breakdown of academic impact, for papers by Mark N. Mead Breakdown of academic impact, for papers by Sung Joon Lee Breakdown of academic impact, for papers by Yutaka Higashi Breakdown of academic impact, for papers by Toshiyuki Kudo Breakdown of academic impact, for papers by Gil‐Tae Gang
Rankless by CCL
2026